Molecular aspects of rheumatoid arthritis: role ofenvironmental factors Shu Kobayashi, Shigeki Momohara, Naoyuki Kamatani and Hiroshi Okamoto Institute of Rheumatology, Tokyo Women’s Med
Trang 1Molecular aspects of rheumatoid arthritis: role of
environmental factors
Shu Kobayashi, Shigeki Momohara, Naoyuki Kamatani and Hiroshi Okamoto
Institute of Rheumatology, Tokyo Women’s Medical University, Japan
Introduction
Rheumatoid arthritis (RA) is a systemic, chronic
inflammatory disease that affects 0.5–1% of the
popu-lation and causes progressive joint destruction that
leads to the restriction of activities of daily living and
deterioration of quality of life Although the
patho-genesis of RA has not yet been fully elucidated, it is
considered to be a complex, multifarious disease that
is influenced by both genetic and environmental
fac-tors Genetic influences that contribute to RA
suscepti-bility have been demonstrated in both studies of twins
[1] and families [2], as well as in genome-wide linkage
scans [3] These studies estimated that genetic factors
are responsible for 50–60% of the risk of developing
RA and that environmental factors may explain the
remaining risk This quantification was made by a
classical approach to separating the quantitative influence of genetic factors in RA with nationwide studies of twins with RA, as described previously [1] This minireview focuses on the contribution of envi-ronmental risk factors to the development of RA
Infection
Several infectious agents have been reported to be risk factors for RA (Table 1), including human parvovirus B19 (B19), Epstein–Barr virus (EBV), retroviruses, alphaviruses, hepatitis B virus, Mycobacterium tuberculo-sis, Escherichia coli, Proteus mirabilis and Mycoplasma Human parvovirus B19 is a small, nonenveloped DNA virus that is transmitted via the respiratory tract
as well as vertically from mother to fetus Although B19 is a significant human pathogen with a wide
Keywords
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD);
cytokines; environmental factors; hormone;
NF-jB; rheumatoid arthritis; smoking;
weather
Correspondence
H Okamoto, Institute of Rheumatology,
Tokyo Women’s Medical University, 10-22
Kawada-cho, Shinjuku, Tokyo 162-0054,
Japan
Fax: +81 3 5269 1726
Tel: +81 3 5269 1725
E-mail: hokamoto@ior.twmu.ac.jp
(Received 14 March 2008, revised 1 June
2008, accepted 20 June 2008)
doi:10.1111/j.1742-4658.2008.06581.x
Rheumatoid arthritis (RA) is a systemic, chronic inflammatory disease that affects 0.5–1% of the population RA causes progressive joint destruction that leads to the restriction of activities of daily living and deterioration of quality of life Although the pathogenesis of RA has not yet been fully elu-cidated, it is considered to be a complex, multifarious disease that is influ-enced by both genetic and environmental factors Genetic influences that contribute to RA susceptibility have been demonstrated both in studies of twins and families, as well as in genome-wide linkage scans, and it is esti-mated that genetic factors are responsible for 50–60% of the risk of devel-oping RA Thus, environmental factors may explain the remaining risk of developing RA A large variety of environmental factors such as infectious agents, smoking, sex hormones, pregnancy etc have been extensively studied previously Understanding of how these factors contribute to the development of RA may lead to the better understanding of pathogenesis
of RA
Abbreviations
AhR, aryl hydrocarbone receptor; B19, human parvovirus B19; CCP, cyclic citrullinated peptide; EBV, Epstein–Barr virus; HLA, human leukocyte antigen; IL, interleukin; JCP, Japanese cedar pollinosis; RA, rheumatoid arthritis; RF, rheumatoid factor; TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin; Th, T helper; TNF-a, tumor necrosis factor-a.
Trang 2clinical spectrum, 25–68% of infections are
asymptom-atic The most common clinical manifestation of acute
infection is erythema infectiosum, characterized by a
‘slapped cheek’ rash Interestingly, 50% of adults and
10% of children with erythema infectiosum have joint
manifestations, which tend to occur 2 weeks after
infection Arthritis caused by B19 infection is usually
symmetrical, primarily affecting the small joints of the
hands, wrists and knees, and it is more commonly
observed in female subjects than in male subjects (as is
RA) Certain evidence suggests that B19 may play a
role in the pathogenesis of RA For example, B19
arthritis often meets the clinical diagnostic criteria for
RA and is sometimes accompanied by bone erosion
and – at least transiently – by rheumatoid factor (RF)
positivity Human parvovirus B19 DNA may be
detected in the synovial fluid, synovial cells and⁄ or
synovial tissue of affected joints Furthermore, a
posi-tive association with the human leukocyte antigen
(HLA)-DR4 antigen has been reported in patients who
developed arthritis after B19 infection [4] Ray et al
reported the ability of B19 to induce certain properties
in normal human synovial fibroblasts [5] These
inves-tigators observed that incubation with B19-containing
serum induces an invasive phenotype in normal human
synovial fibroblasts and that B19 serum-treated
synovial fibroblasts exhibit an increase in invasiveness
compared with fibroblasts cultured in medium contain-ing B19-negative serum or in medium alone Synovio-cyte migration has been shown to be induced by the B19 VP1 protein unique region, with the phospholi-pase activity of the VP1 protein unique region being prerequisite for this process [6] Infection of the macro-phage cell line U937 or bone marrow cells with B19 has been shown to induce the expression of interleukin (IL)-6 and tumor necrosis factor-a (TNF-a), which are both key cytokines in RA pathogenesis [7] A recent report showed evidence of the high prevalence of B19 DNA in patients with RA [8] However, a significant amount of evidence contradicts a role of B19 infection
in RA pathogenesis For example, a long-term (median
5 years) follow-up study among 54 patients with recent B19 infection revealed that none of the patients with acute-phase arthalgia developed chronic arthritis [9] In addition, genomic B19 DNA has been shown to persist not only in the synovial membranes of patients with chronic arthropathy, but also in healthy, immuno-competent individuals [10] Furthermore, nested PCR amplification of both NS1 and VP genes of B19 DNA
in synovial membranes has revealed that the levels of B19 DNA are similar in RA and control synovial membranes [11] Thus, the contribution of B19 infec-tion in RA remains controversial
Epstein–Barr virus is a 172-kb, double-stranded DNA virus It causes infectious mononucleosis and has been linked to the development of several malignant tumors, including Burkitt’s lymphoma, Hodgkin’s disease and nasopharyngeal carcinoma In most indivi-duals, primary infection is asymptomatic Epstein–Barr virus first infects B lymphocytes or epithelial cells of the oropharynx and then activates resting B lymphocytes, which is followed by proliferation; the virus then estab-lishes a so-called ‘latent infection’ in memory B lympho-cytes A potential role of EBV in RA pathogenesis has been proposed for many years [12] For example, it has been reported that sera from RA patients contains high-titer antibodies to latent and replicative EBV antigens, such as Epstein–Barr nuclear antigen, viral capsid anti-gen and early antianti-gen [13,14] Furthermore, RA patients tend to have more EBV-infected B lymphocytes in their peripheral blood than normal control individuals, and the mean frequency of spontaneously transforming B lymphocytes is five times higher in RA patients than in controls The QKRAA amino acid sequence of the HLA-DRB1*0401 allele, which is associated with RA disease susceptibility, is also found on the EBV glyco-protein gp110 [15], a major replicative antigen impli-cated in the control of infection and that is expressed
on the surface of lymphoblastoid cell lines and on the envelope of the budding virion during EBV replication
Table 1 Risk and defensive factors for RA.
Risk factors Defensive factors
Infection Human parvovirus B19 [4–8]
Epstein–Barr virus [12–17]
Human retrovirus 5 [18]
Alphaviruses [22–24]
Hepatitis B virus [25]
Mycoplasma [26]
Mycobacterium
tuberculosis [27]
Smoking Smoking [28–36]
Sex hormones Estrogen [37] Testosterone [37]
Oral contraceptive pill [39]
Complications Type 1 diabetes
mellitus [48]
Autoimmune thyroid
disease [48]
acids [50]
Vitamin D [52], vitamin K [53]
Weather Low temperature [54,55]
High atmospheric
pressure [54]
High humidity [54]
Trang 3Healthy individuals with prior EBV infection have
serum antibodies to gp110, and their T lymphocytes
recognize peptides containing the QKRAA motif gp110
is a target for both T lymphocytes and certain
anti-bodies, recognition of which allows control of infection
Conversely, HLA-DRB1*0404, an RA predisposing
allele, is associated with low T-lymphocyte responses to
gp110 In RA patients, poor control of EBV replication
may result in a higher EBV load In situ hybridization
experiments have demonstrated the presence of
EBV-encoded RNAs in synovial tissue B lymphocytes from
RA patients, but not in tissue from osteoarthritis
patients Furthermore, semiquantitative PCR
tech-niques have been used to show that EBV DNA is
detected more frequently in peripheral blood
mononu-clear cells, synovial fluid and saliva from RA patients
than from controls and patients with other arthritides
[16] An EBV DNA quantification assay using real-time
PCR revealed that the EBV DNA load is significantly
higher in peripheral blood mononuclear cells from RA
patients than in peripheral blood mononuclear cells
from patients with non-RA inflammatory diseases and
normal control individuals In addition, the EBV load
in RA patients expressing HLA-DRB1*0404 is slightly
higher than that observed in patients expressing
HLA-DRB1*07 [17]
Although human retroviruses have long been
suspected as triggering factors in autoimmune diseases,
no conclusive evidence confirming these suspicions has
been reported thus far One group reported that
human retrovirus 5 proviral DNA was detected in
53% of synovial samples from arthritic joints, in 12%
of blood samples from RA patients and in 16% of
blood samples from patients with systemic lupus
eryth-ematosus [18] However, data from another group
con-tradicts this initial observation, with no association
identified between human retrovirus 5 and RA [19,20]
Human retrovirus 5 has been suggested to be a rabbit
endogenous retrovirus [21]
Infections with alphaviruses, such as chikungunya
virus, Ross Rover virus and Sindbis virus have been
reported to be associated with the onset of arthritis
[22–24] There are some reports showing that chronic
infection with HBV may cause arthritis similar to RA
and that RF is present in 20–75% of the patients, but
rarely is antibody against cyclic citrullinated peptide
(anti-CCP) detected, which is a more specific marker
of RA than RF [25] Although these types of arthritis
are not always acute and chronic arthritis can be
developed, there is no evidence to date showing that
these types of arthritis progress into RA
In one study, Mycoplasma DNA was reported to be
amplified from the peripheral blood of 53.6% (15⁄ 28)
of RA patients, suggesting that a high percentage of
RA patients have systemic mycoplasmal infections [26] M tuberculosis is a chronic infectious disease affecting the lungs Although a mild increase in the risk of encountering tuberculosis in RA patients was reported more recently, this increase was found even among patients receiving therapies with biological agents [27]
These associations between RA and infectious agents have been supported by increased antibody titers or DNA to the infectious organism in RA patients com-pared with other individuals However, some epidemi-ological studies oppose these possible links, and there has been no consistent evidence that a single infectious agent or other environmental factor is responsible for the effect of the environment on RA Therefore, the pathological role of these and other infectious agents needs to be explored further
Smoking
A large number of epidemiological studies have dem-onstrated an association between cigarette smoking and the development of RA [28–31] In particular, smoking is known to be associated with RF-positive
RA and anti-CCP-positive RA [32], and to interact with the HLA-DRB1 shared epitope alleles [33] In addition, some studies have suggested that smoking also influences RA disease severity [34,35], although this remains controversial While the mechanisms responsible for the influence of smoking in RA are not clear, some studies have shown an association between
RA and the toxic compounds found in cigarette smoke, such as nicotine, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and reactive oxygen species We found that the mRNA and protein levels of aryl hydrocarbone receptor (AhR) were higher in RA syno-vial tissue than in osteoarthritis tissue, and that TCDD upregulated the expression of IL-1b, IL-6 and IL-8 through binding to AhR, with this effect transmitted via the nuclear factor-jB and extracellular signal-regu-lated kinase signaling cascades In addition, AhR expression in synovial cells was upregulated by TNF-a These data suggest that TNF-a activates AhR expres-sion in RA synovial tissue, and that cigarette smoking and exposure to TCDD enhance RA inflammatory pro-cesses (Fig 1) Thus, TCDD exposure, such as smoking, appears to exacerbate RA pathogenesis [36]
Sex hormones
The increased risk of RA in women has led to evaluation
of the role of sex hormones in disease susceptibility It is
Trang 4well known that the levels of male sex hormones,
parti-cularly testosterone, are lower in men who have RA By
contrast, the levels of female sex hormones do not differ
significantly between RA patients and control individu-als [37] It has been reported that bone erosion occurs more frequently in men than in women, and that arthri-tis tends to occur earlier in men Furthermore, male gender is correlated with a higher risk of bony erosions and an accelerated disease course, while female gender
is correlated with structural consequences of joint destruction Joint surgery is performed more frequently
in female RA patients than in male patients In addition, gender influences the risk, as well as the pattern, of organ involvement in RA: nodules and rheumatoid lung disease are typical manifestations in men, whereas women typically develop sicca syndrome [38]
Exogenous hormones have also been reported to influence RA disease risk For example, several studies have shown that women who use oral contraceptive pills have a reduced risk of developing RA [39] On the other hand, Walitt et al reported that there were no statisti-cally significant differences in the risk of developing RA
or the severity of RA between postmenopausal hormone therapy groups and placebo groups [40] The molecular mechanisms underlying hormone involvement in RA pathogenesis require further elucidation
Pregnancy
It is widely accepted that RA frequently remits during pregnancy Although the mechanism for this is unclear, Nelson et al [41] reported that the amelio-ration of RA during pregnancy is associated with a disparity in HLA class II antigens between mother and fetus These investigators suggested that the maternal immune response to paternal HLA antigens may play
a role in pregnancy-induced RA remission By con-trast, several studies have suggested that nulliparous women have an increased risk of developing RA, although there is no increased risk in women who are single [42] These reports support the hypothesis that pregnancy is related to the development of RA Recent studies have also suggested that the risk of disease development is increased during the postpartum period, particularly after the first pregnancy [43,44] Subsequent investigations demonstrated that much of this increased risk is associated with breastfeeding, and that women who breastfeed after their first pregnancy are at the greatest risk of developing RA [45] These researchers also suggested that the association among breastfeeding, pregnancy and RA may be related to either increased prolactin levels or an abnormal, pro-inflammatory response to prolactin [46] Recently, Forger et al showed that the amelioration of disease activity in the third trimester corresponded to the increased number of regulatory T cells that induced a
400
A
B
300
IL-6 IL-8
200
–1 )
0
100
0.4
0.8
–1 )
None
TCDD (n M )
0
TCDD (smoking, etc.)
(RA joint space)
TNF- α
AhR
(RA synoviocyte)
ERK NF- κΒ
Target gene
(nucleus)
Fig 1 (A) TCDD increases IL-1b, IL-6 and IL-8 production from
fibroblast-like synoviocytes obtained from patients with RA
Fibro-blast-like synoviocytes were stimulated with various concentrations
of TCDD (0–100 n M ) for 12 h and the cytokine concentrations in
fibroblast-like synoviocyte culture supernatants were determined
using cytokine-specific ELISA kits [36] (B) Schematic
representa-tion of the role of AhR in RA TCDD, a major component of
ciga-rette smoke, enhances the RA inflammatory process TCDD
induces inflammatory cytokines via its association with AhR,
result-ing in stimulation of the nuclear factor-jB (NF-jB) and extracellular
signal-regulated kinase (ERK) signaling cascades In RA joints,
strong expression of AhR occurs as a result of TNF-a
over-produc-tion, a well-known pathological feature of RA Exposure to TCDD
induces the release of additional pro-inflammatory cytokines,
result-ing in RA exacerbation.
Trang 5pronounced anti-inflammatory cytokine milieu They
suggested that pregnancy leads to a beneficial effect of
regulatory T cells on RA disease activity [47]
Complications
Numerous studies have examined disease-related
com-plications that occur at an increased frequency in both
RA patients and their families The most widely
investi-gated of these complications are other autoimmune
diseases, particularly type 1 diabetes mellitus and
autoimmune thyroid disease [48] Rheumatoid arthritis
is known to be a T helper (Th) 1-dominant disease,
whereas atopic allergy is a Th2-dominant disease
Therefore, a functional dichotomy between
Th1-domi-nated immune reactions in RA and Th2-mediated
immune reactions typical of atopic allergy, including
Japanese cedar pollinosis (JCP), has been suggested We
investigated the occurrence of JCP in RA patients and
compared RA disease activity between RA patients with
JCP and those without JCP using a large observational
cohort study of RA patients [The 6th Japanese version
of the IORRA study (Institute Of Rheumatology,
Rheu-matoid Arthritis)] We concluded that RA disease
activ-ity tends to be negatively associated with the presence of
JCP and speculated that patients with JCP have a
genetic predisposition to develop milder RA [49]
Diet
Few reports have addressed the influence of diet on RA
development and progression The addition of omega-3
fatty acids to the diets of RA patients has been
associ-ated with improvement in RA [50] Furthermore, diets
high in eicosapentaenoic acid have a favourable effect
on the clinical outcome of RA [51] Although the
asso-ciation between diet and RA onset is unclear, it is
accepted that such fatty acids compete with arachidonic
acids, the latter of which are involved in inflammation
Some reports have demonstrated the influence of
vita-mins on RA For example, greater intake of vitamin D,
primarily from fish and fish products, has been
associ-ated with a lower risk of RA [52] In addition, we
recently reported that vitamin K, which is primarily
derived from vegetables and legumes [particularly
fer-mented soybeans (natto)], could inhibit the proliferation
of fibroblast-like synoviocytes and the development of
collagen-induced arthritis [53]
Weather conditions
Although no good biologic hypotheses have been
proposed that might explain the association between
RA and weather conditions, Strusberg et al reported that low temperature, high atmospheric pressure and high humidity were significantly correlated with pain
in RA patients [54] Verges et al suggested that some meteorological variables affect the occurrence of pain
in RA and that low temperature increases the risk of joint pain [55]
Concluding remarks
A large variety of environmental factors have been proposed to be associated with RA development However, many epidemiological studies have reported inconsistent results, so such associations are controver-sial In addition, little is known about the underlying mechanisms Further research is required to gain a better understanding of the impact of these environ-mental factors on human immunity and their effects
on RA disease outcomes
References
1 MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K & Silman AJ (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis Rheum 43, 30–37
2 Bali D, Gourley S, Kostyu DD, Goel N, Bruce I, Bell
A, Walker DJ, Tran K, Zhu DK, Costello TJ et al (1999) Genetic analysis of multiplex rheumatoid arthri-tis families Genes Immun 1, 28–36
3 Corne´lis F, Faure´ S, Martinez M, Prud’homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa
A et al (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study Proc Natl Acad Sci U S A 95, 10746–10750
4 Franssila R & Hedman K (2006) Infection and musculo-skeletal conditions: viral causes of arthritis Best Pract Res Clin Rheumatol 20, 1139–1157
5 Ray NB, Nieva DR, Seftor EA, Khalkhali-Ellis Z & Naides SJ (2001) Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibro-blasts Arthritis Rheum 44, 1582–1586
6 Lu J, Zhi N, Wong S & Brown KE (2006) Activation
of synoviocytes by the secreted phospholipase A2 motif
in the VP1-unique region of parvovirus B19 minor capsid protein J Infect Dis 193, 582–590
7 Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii
T, Ishii K, Saitoh T, Sawai T, Sugamura K & Sasaki T (1998) Human parvovirus B19 as a causative agent for rheumatoid arthritis Proc Natl Acad Sci U S A 95, 8227–8232
8 Kozireva SV, Zestkova JV, Mikazane HJ, Kadisa AL, Kakurina NA, Lejnieks AA, Danilane IN & Murovska
Trang 6MF (2008) Incidence and clinical significance of
parvovirus B19 infection in patients with rheumatoid
arthritis J Rheumatol 35, 1265–1270
9 Speyer I, Breedveld FC & Dijkmans BA (1998) Human
parvovirus B19 infection is not followed by inflammatory
joint disease during long term follow-up A retrospective
study of 54 patients Clin Exp Rheumatol 16, 576–578
10 So¨derlund M, von Essen R, Haapasaari J, Kiistala U,
Kiviluoto O & Hedman K (1997) Persistence of
parvo-virus B19 DNA in synovial membranes of young
patients with and without chronic arthropathy Lancet
349, 1063–1065
11 Peterlana D, Puccetti A, Beri R, Ricci M, Simeoni S,
Borgato L, Scilanga L, Ceru` S, Corrocher R & Lunardi
C (2003) The presence of parvovirus B19 VP and NS1
genes in the synovium is not correlated with rheumatoid
arthritis J Rheumatol 30, 1907–1910
12 Posnett DN (2008) Herpesviruses and autoimmunity
Curr Opin Investig Drugs 9, 505–514
13 Alspaugh MA, Talal N & Tan EM (1976) Differentiation
and characterization of autoantibodies and their antigens
in Sjogren’s syndrome Arthritis Rheum 19, 216–222
14 Alspaugh MA, Henle G, Lennette ET & Henle W
(1981) Elevated levels of antibodies to Epstein-Barr
virus antigens in sera and synovial fluids of patients
with rheumatoid arthritis J Clin Invest 67, 1134–1140
15 Roudier J, Petersen J, Rhodes GH, Luka J & Carson
DA (1989) Susceptibility to rheumatoid arthritis maps
to a T-cell epitope shared by the HLA-Dw4 DR beta-1
chain and the Epstein-Barr virus glycoprotein gp110
Proc Natl Acad Sci U S A 86, 5104–5108
16 Balandraud N, Roudier J & Roudier C (2004)
Epstein-Barr virus and rheumatoid arthritis Autoimmun Rev 3,
362–367
17 Balandraud N, Meynard JB, Auger I, Sovran H,
Mugnier B, Reviron D, Roudier J & Roudier C (2003)
Epstein-Barr virus load in the peripheral blood of
patients with rheumatoid arthritis: accurate
quantifica-tion using real-time polymerase chain reacquantifica-tion Arthritis
Rheum 48, 1223–1228
18 Griffiths DJ, Cooke SP, Herve´ C, Rigby SP, Mallon E,
Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P
et al.(1999) Detection of human retrovirus 5 in patients
with arthritis and systemic lupus erythematosus
Arthri-tis Rheum 42, 448–454
19 Piper KE, Hanssen AD, Lewallen DG, Matteson EL,
Osmon DR, Duffy MC, Hagan RA, Steckelberg JM &
Patel R (2006) Lack of detection of human retrovirus-5
proviral DNA in synovial tissue and blood specimens
from individuals with rheumatoid arthritis or
osteo-arthritis Arthritis Rheum 55, 123–125
20 Gaudin P, Moutet F, Tuke PW & Garson JA (1999)
Absence of human retrovirus 5 in French patients with
rheumatoid arthritis: comment on the article by
Griffiths et al Arthritis Rheum 42, 2492–2494
21 Forsman A, Uzameckis D, Ro¨nnblom L, Baecklund E, Aleskog A, Bindra A, Pipkorn R, Lejniece S, Kozireva
S, Murovska M et al (2003) Single-tube nested quanti-tative PCR: a rational and sensitive technique for detec-tion of retroviral DNA Applicadetec-tion to
RERV-H⁄ HRV-5 and confirmation of its rabbit origin
J Virol Methods 111, 1–11
22 Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl
SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ & Mahalingam S (2008) Macrophage-derived proinflammatory factors contribute to the development
of arthritis and myositis after infection with an arthro-genic alphavirus J Infect Dis, doi: 10.1086/587841
23 Calabrese LH (2008) Emerging viral infections and arthritis: the role of the rheumatologist Nat Clin Pract Rheumatol 4, 2–3
24 Kurkela S, Helve T, Vaheri A & Vapalahti O (2008) Arthritis and arthralgia three years after Sindbis virus infection: clinical follow-up of a cohort of 49 patients Scand J Infect Dis 40, 167–173
25 Maya R, Gershwin ME & Shoenfeld Y (2008) Hepatitis
B virus (HBV) and autoimmune disease Clin Rev Allergy Immunol 34, 85–102
26 Haier J, Nasralla M, Franco AR & Nicolson GL (1999) Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis Rheumatology (Oxford) 38, 504–509
27 Askling J, Fored CM, Brandt L, Baecklund E, Bertils-son L, Co¨ster L, Geborek P, JacobsBertils-son LT, Lindblad
S, Lysholm J et al (2005) Risk and case characteristics
of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden Arthritis Rheum 52, 1986–1992
28 Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries
RR & Cats A (1990) Lifestyle and the risk of rheuma-toid arthritis: cigarette smoking and alcohol consump-tion Ann Rheum Dis 49, 980–982
29 Heliovaara M, Aho K, Aromaa A, Knekt P & Reuna-nen A (1993) Smoking and risk of rheumatoid arthritis
J Rheumatol 20, 1830–1835
30 Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lund-berg I, Klareskog L, Alfredsson L & EIRA study group (2003) Quantification of the influence of cigarette smok-ing on rheumatoid arthritis: results from a population based case-control study, using incident cases Ann Rheum Dis 62, 835–841
31 Voigt LF, Koepsell TD, Nelson JL, Dugowson CE & Daling JR (1994) Smoking, obesity, alcohol consump-tion, and the risk of rheumatoid arthritis Epidemiology
5, 525–532
32 Klareskog L, Stolt P, Lundberg K, Ka¨llberg H, Bengts-son C, Grunewald J, Ro¨nnelid J, Harris HE, Ulfgren
AK, Rantapa¨a¨-Dahlqvist S et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune
Trang 7reactions to autoantigens modified by citrullination.
Arthritis Rheum 54, 38–46
33 Padyukov L, Silva C, Stolt P, Alfredsson L &
Klare-skog L (2004) A gene-environment interaction between
smoking and shared epitope genes in HLA-DR provides
a high risk of seropositive rheumatoid arthritis Arthritis
Rheum 50, 3085–3092
34 Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield
A, Thomson W, Hajeer AH & Ollier WE (2002)
Smok-ing and disease severity in rheumatoid arthritis:
associa-tion with polymorphism at the glutathione S-transferase
M1 locus Arthritis Rheum 46, 640–646
35 Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis
EK, Tsifetaki N & Drosos AA (2005) Does cigarette
smoking influence disease expression, activity and
sever-ity in early rheumatoid arthritis patients? Clin Exp
Rheumatol 23, 861–866
36 Kobayashi S, Okamoto H, Iwamoto T, Toyama Y,
Tomatsu T, Yamanaka H & Momohara S (2008) A role
for the aryl hydrocarbon receptor and the dioxin TCCD
in rheumatoid arthritis Rheumatology, doi: 10.1093/
rheumatology/ken259
37 Heikkila¨ R, Aho K, Helio¨vaara M, Knekt P, Reunanen
A, Aromaa A, Leino A & Palosuo T (1998) Serum
androgen-anabolic hormones and the risk of
rheuma-toid arthritis Ann Rheum Dis 57, 281–285
38 Weyand CM, Schmidt D, Wagner U & Goronzy JJ
(1998) The influence of sex on the phenotype of
rheumatoid arthritis Arthritis Rheum 41, 817–
822
39 Brennan P, Bankhead C, Silman A & Symmons D
(1997) Oral contraceptives and rheumatoid
arthri-tis: results from a primary care-based incident
case-control study Semin Arthritis Rheum 26, 817–
823
40 Walitt B, Pettinger M, Weinstein A, Katz J, Torner J,
Wasko MC, Howard BV & Women’s Health Initiative
Investigators (2008) Effects of postmenopausal
hormone therapy on rheumatoid arthritis: the women’s
health initiative randomized controlled trials Arthritis
Rheum 59, 302–310
41 Nelson JL, Hughes KA, Smith AG, Nisperos BB,
Branchaud AM & Hansen JA (1993) Maternal-fetal
disparity in HLA class II alloantigens and the
pregnancy-induced amelioration of rheumatoid arthritis
N Engl J Med 329, 466–471
42 Silman AJ (1994) Epidemiology of rheumatoid arthritis
Apmis 102, 721–728
43 Nelson JL & Ostensen M (1997) Pregnancy and rheumatoid arthritis Rheum Dis Clin North Am 23, 195–212
44 Silman A, Kay A & Brennan P (1992) Timing of pregnancy in relation to the onset of rheumatoid arthritis Arthritis Rheum 35, 152–155
45 Brennan P & Silman A (1994) Breast-feeding and the onset of rheumatoid arthritis Arthritis Rheum 37, 808–813
46 Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, Silman A & Ollier B (1997) Allelic mark-ers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus Arthritis Rheum 40, 1383–1386
47 Forger F, Marcoli N, Gadola S, Moller B, Villiger PM
& Ostensen M (2008) Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis Ann Rheum Dis 67, 984–990
48 Silman AJ, Ollier WE & Bubel MA (1989) Autoimmune thyroid disease and thyroid autoantibodies in rheuma-toid arthritis patients and their families Br J Rheumatol
28, 18–21
49 Koizumi K, Okamoto H, Kamitsuji S, Sato E, Suzuki
K, Yamanaka H, Hara M, Tomatsu T & Kamatani N (2007) The occurrence of Japanese cedar pollinosis with rheumatoid arthritis Clin Exp Rheumatol 25, 505–506
50 Ariza-Ariza R, Mestanza-Peralta M & Cardiel MH (1998) Omega-3 fatty acids in rheumatoid arthritis: an overview Semin Arthritis Rheum 27, 366–370
51 Volker D, Fitzgerald P, Major G & Garg M (2000) Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis J Rheumatol 27, 2343–2346
52 Cutolo M, Otsa K, Uprus M, Paolino S & Seriolo B (2007) Vitamin D in rheumatoid arthritis Autoimmun Rev 7, 59–64
53 Okamoto H, Shidara K, Hoshi D & Kamatani N (2007) Anti-arthritis effects of vitamin K(2) (mena-quinone-4) – a new potential therapeutic strategy for rheumatoid arthritis FEBS J 274, 4588–4594
54 Strusberg I, Mendelberg RC, Serra HA & Strusberg
AM (2002) Influence of weather conditions on rheumatic pain J Rheumatol 29, 335–338
55 Verge´s J, Montell E, Toma`s E, Cumelles G, Castan˜eda
G, Marti N & Mo¨ller I (2004) Weather conditions can influence rheumatic diseases Proc West Pharmacol Soc
47, 134–136